Advances in biomarkers, blood tests and disease-modifying therapies have created a credible path to clinical prevention of Alzheimer disease (AD). In this Perspective, the authors discuss promising approaches to the prevention of AD and highlight strategic gaps.
- Jorge J. Llibre-Guerra
- Eric M. McDade
- Randall J. Bateman